This inventor holds 3 USPTO granted patents and 2 EPO patents. Top assignees: Lek Pharmaceuticals D.d., Other. Active years: 2011-2014.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2011-2014
Title: Gorazd Sorsak: Innovator in Pharmaceutical Chemistry
Introduction
Gorazd Sorsak is a notable inventor based in Ljubljana, Slovenia. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the preparation of atorvastatin calcium. With a total of 3 patents, Sorsak's work has advanced the understanding and application of this important compound.
Latest Patents
Sorsak's latest patents include innovative processes for the preparation of amorphous calcium salt of atorvastatin. One of his notable inventions describes a method that involves creating a reaction mixture with a pH between 6.5 and 8.0, which contains a sodium salt of atorvastatin and tetrahydrofuran. The process further includes the addition of a non-cyclic chlorinated organic solvent or a cyclic hydrocarbon solvent to facilitate the formation of amorphous atorvastatin calcium. Another patent focuses on preparing amorphous atorvastatin calcium without the need for intermediate isolation of crystals, streamlining the production process.
Career Highlights
Throughout his career, Gorazd Sorsak has worked with prominent companies, including Lek Pharmaceuticals D.d. His expertise in pharmaceutical processes has been instrumental in developing effective formulations and improving production techniques.
Collaborations
Sorsak has collaborated with notable colleagues such as Ljubomir Antoncic and Anton Copar. These partnerships have contributed to the advancement of his research and the successful implementation of his patented processes.
Conclusion
Gorazd Sorsak's contributions to pharmaceutical chemistry, particularly in the preparation of atorvastatin calcium, highlight his innovative spirit and dedication to advancing medical science. His patents reflect a commitment to improving pharmaceutical processes and enhancing the efficacy of important medications.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile